• -
  • English
  • Japanese
  • Korean
市場調查報告書
商品編碼
923971

醫藥品連續生產的全球市場:各產品、用途、終端用戶的市場機會與產業預測(2019年∼2026年)

Pharmaceutical Continuous Manufacturing Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2019-2026
出版日期: | 出版商: Allied Market Research | 英文 245 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球醫藥品連續生產市場，2018年價值3億9,300萬美元，預計從2019年到2026年以10.2％的年複合成長率發展，到2026年成長到8億5,500萬美元。從傳統的醫藥品生產流程轉移到醫藥品連續生產，連續生產系統的技術進步，發展中國家的連續生產系統的認識度提高，生產量的變動縮小，產量比率的改善，運用成本的降低等要素，預計促進這個市場成長。

本報告提供全球醫藥品連續生產市場調查，市場概要，各產品、用途、終端用戶、地區的市場規模的變化與預測，市場成長要素及阻礙因素分析，市場機會，競爭情形，主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 報告概要
  • 相關利益者的主要好處
  • 主要市場區隔
  • 調查方法

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 影響要素分析

第4章 全球醫藥品連續生產市場:各產品

  • 概要
    • 市場規模與預測
  • 整合連續系統
    • 主要市場趨勢與機會
    • 市場規模與預測:各地區
    • 市場分析:各國
  • 半連續系統
  • 控制、軟體

第5章 全球醫藥品連續生產市場:各用途

  • 概要
    • 市場規模與預測
  • 最終產品
  • 醫藥品原料藥(API)製造
    • 市場規模與預測
    • 市場分析:各國

第6章 全球醫藥品連續生產市場:各終端用戶

  • 概要
    • 市場規模與預測
  • 製藥企業
    • 市場規模與預測
    • 市場分析:各國
  • CRO
  • 其他

第7章 全球醫藥品連續生產市場:各地區

  • 概要
    • 市場規模與預測
  • 北美
    • 主要的市場趨勢、成長要素，市場機會
    • 市場規模與預測:各國
    • 北美的市場規模與預測:各產品
    • 北美的市場規模與預測:各用途
    • 北美的市場規模與預測:各終端用戶
  • 歐洲
  • 亞太地區
  • 南美、中東、非洲

第8章 企業簡介

  • Coperion Gmbh
  • Gea Group Ag
  • Gebruder Lodige Maschinenbau Gmbh
  • Glatt Gmbh
  • hosokawamikuron
  • Korsch Ag
  • L.B. Bohle Maschinen + Verfahren Gmbh
  • Munson Machinery Company, Inc.
  • Robert Bosch Packaging Technology Gmbh
  • Thermo Fisher Scientific, Inc.
目錄
Product Code: LI_196240

The global pharmaceutical continuous manufacturing market was valued at $393 million in 2018, and is projected to reach $855 million by 2026, registering a CAGR of 10.2% from 2019 to 2026.

Continuous manufacturing is advanced manufacturing approach that is performed by employing end-to-end integration of manufacturing subprocesses with a significant level of control strategies.

The growth of the global pharmaceutical continuous manufacturing market is anticipated to be driven by increase in adoption of continuous manufacturing systems over existing drug manufacturing process, technological advancements in CM systems, and rise in awareness of continuous manufacturing systems in developing regions are anticipated to significantly boost the growth of the pharmaceutical continuous manufacturing market during the forecast period. Continuous pharmaceutical manufacturing system offers advantages such as reduced fluctuation in production, improved yields, lower cost of operation & equipment further augment the market growth.

Moreover, initiatives taken by the Food and drug Administration (FDA) for promoting the use of pharmaceutical continuous manufacturing systems and advantage of CM systems over the batch manufacturing are the major factors to boost the growth of pharmaceutical continuous manufacturing market. However, higher cost of pharmaceutical continuous manufacturing systems impede the market growth.

Moreover, the CM process is more time-efficient, reduces energy needs, helps to increase productivity, and minimizes overall waste, which are expected to offer lucrative opportunity for the pharmaceutical continuous manufacturing market during the forecast period.

The global pharmaceutical continuous manufacturing market is segmented into product, application, end user, and region. On the basis of product, the market is classified into integrated continuous systems, semicontinuous systems, and control & software. By application, it is divided into final drug product manufacturing and API manufacturing. Depending on end user, it is categorized into pharmaceutical companies, contract manufacturing organizations, and others. Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.

It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.

A comprehensive analysis of four major regions is provided to determine the existing opportunities.

The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Product

  • Integrated Continuous Systems
  • Semicontinuous Systems
  • Control & Software
  • Application Type
  • Final Drug Product Manufacturing
  • API Manufacturing
  • End User
  • Pharmaceutical Companies
  • Contract Manufacturing Organizations
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • Bosch Packaging Technology
  • Coperion GmbH
  • GEA Group AG
  • Gebruder Lodige Maschinenbau GmbH
  • Glatt GmbH
  • Hosokawa Micron Corporation
  • Korsch AG
  • L.B. Bohle Maschinen + Verfahren GmbH
  • Munson Machinery Company, Inc.
  • Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1: Introduction

  • 1.1. Report Description
  • 1.2. Key Benefits For Stakeholders
  • 1.3. Key Market Segments
    • 1.3.1. List of Key Players Profiled In The Report
  • 1.4. Research Methodology
    • 1.4.1. Secondary Research
    • 1.4.2. Primary Research
    • 1.4.3. Analyst Tools And Models

Chapter 2: Executive Summary

  • 2.1. Key Findings of The Study
  • 2.2. Cxo Perspective

Chapter 3: Market Overview

  • 3.1. Market Definition And Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Market Player Positioning, 2018
  • 3.3. Market Dynamics
    • 3.3.1. Drivers
      • 3.3.1.1. Increase In Government Support For Continuous Manufacturing Adoption
      • 3.3.1.2. Advantages offered By Continuous Manufacturing Systems
      • 3.3.1.3. Surge In Adoption of Pharmaceutical Continuous Manufacturing Systems
    • 3.3.2. Restraint
      • 3.3.2.1. Poor Demand In Under Developed Countries
    • 3.3.3. Opportunities
      • 3.3.3.1. Growth Opportunities In Emerging Markets
    • 3.3.4. Impact Analysis

Chapter 4: Pharmaceutical Continuous Manufacturing Market, By Product

  • 4.1. Overview
    • 4.1.1. Market Size And Forecast
  • 4.2. Integrated Continuous Systems
    • 4.2.1. Key Market Trends And Opportunities
    • 4.2.2. Market Size And Forecast, By Region
    • 4.2.3. Market Analysis, By Country
  • 4.3. Semi-Continuous Systems
    • 4.3.1. Key Market Trends And Opportunities
    • 4.3.2. Market Size And Forecast, By Region
    • 4.3.3. Market Analysis, By Country
  • 4.4. Control & Software
    • 4.4.1. Key Market Trends And Opportunities
    • 4.4.2. Market Size And Forecast, By Region
    • 4.4.3. Market Analysis, By Country

Chapter 5: Pharmaceutical Continuous Manufacturing Market, By Application

  • 5.1. Overview
    • 5.1.1. Market Size And Forecast
  • 5.2. Final Drug Product Manufacturing
    • 5.2.1. Market Size And Forecast
    • 5.2.2. Market Analysis, By Country
  • 5.3. Api Manufacturing
    • 5.3.1. Market Size And Forecast
    • 5.3.2. Market Analysis, By Country

Chapter 6: Pharmaceutical Continuous Manufacturing Market, By End User

  • 6.1. Overview
    • 6.1.1. Market Size And Forecast
  • 6.2. Pharmaceutical Companies
    • 6.2.1. Market Size And Forecast
    • 6.2.2. Market Analysis, By Country
  • 6.3. Contract Manufacturing Organizations
    • 6.3.1. Market Size And Forecast
    • 6.3.2. Market Analysis, By Country
  • 6.4. Others
    • 6.4.1. Market Size And Forecast
    • 6.4.2. Market Analysis, By Country

Chapter 7: Pharmaceutical Continuous Manufacturing Market, By Region

  • 7.1. Overview
    • 7.1.1. Market Size And Forecast
  • 7.2. North America
    • 7.2.1. Key Market Trends, Growth Factors, And Opportunities
    • 7.2.2. Market Size And Forecast, By Country
      • 7.2.2.1. U.S.
      • 7.2.2.1.1. U.S. Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.2.2.1.2. U.S. Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.2.2.1.3. U.S. Pharmaceutical Continuous Manufacturing Market, By End User
      • 7.2.2.2. Canada
      • 7.2.2.2.1. Canada Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.2.2.2.2. Canada Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.2.2.2.3. Canada Pharmaceutical Continuous Manufacturing Market, By End User
      • 7.2.2.3. Mexico
      • 7.2.2.3.1. Mexico Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.2.2.3.2. Mexico Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.2.2.3.3. Mexico Pharmaceutical Continuous Manufacturing Market, By End User
    • 7.2.3. North America Market Size And Forecast, By Product
    • 7.2.4. North America Market Size And Forecast, By Application
    • 7.2.5. North America Market Size And Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends, Growth Factors, And Opportunities
    • 7.3.2. Market Size And Forecast, By Country
      • 7.3.2.1. Germany
      • 7.3.2.1.1. Germany Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.3.2.1.2. Germany Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.3.2.1.3. Germany Pharmaceutical Continuous Manufacturing Market, By End User
      • 7.3.2.2. France
      • 7.3.2.2.1. France Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.3.2.2.2. France Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.3.2.2.3. France Pharmaceutical Continuous Manufacturing Market, By End User
      • 7.3.2.3. Uk
      • 7.3.2.3.1. Uk Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.3.2.3.2. Uk Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.3.2.3.3. Uk Pharmaceutical Continuous Manufacturing Market, By End User
      • 7.3.2.4. Italy
      • 7.3.2.4.1. Italy Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.3.2.4.2. Italy Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.3.2.4.3. Italy Pharmaceutical Continuous Manufacturing Market, By End User
      • 7.3.2.5. Rest of Europe
      • 7.3.2.5.1. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.3.2.5.2. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.3.2.5.3. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By End User
    • 7.3.3. Europe Market Size And Forecast, By Product
    • 7.3.4. Europe Market Size And Forecast, By Application
    • 7.3.5. Europe Market Size And Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends, Growth Factors, And Opportunities
    • 7.4.2. Market Size And Forecast, By Country
      • 7.4.2.1. Japan
      • 7.4.2.1.1. Japan Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.4.2.1.2. Japan Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.4.2.1.3. Japan Pharmaceutical Continuous Manufacturing Market, By End User
      • 7.4.2.2. China
      • 7.4.2.2.1. China Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.4.2.2.2. China Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.4.2.2.3. China Pharmaceutical Continuous Manufacturing Market, By End User
      • 7.4.2.3. India
      • 7.4.2.3.1. India Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.4.2.3.2. India Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.4.2.3.3. India Pharmaceutical Continuous Manufacturing Market, By End User
      • 7.4.2.4. Rest of Asia-Pacific
      • 7.4.2.4.1. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.4.2.4.2. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.4.2.4.3. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By End User
    • 7.4.3. Asia-Pacific Market Size And Forecast, By Product
    • 7.4.4. Asia-Pacific Market Size And Forecast, By Application
    • 7.4.5. Asia-Pacific Market Size And Forecast, By End User
  • 7.5. Lamea
    • 7.5.1. Key Market Trends, Growth Factors, And Opportunities
    • 7.5.2. Market Size And Forecast, By Country
      • 7.5.2.1. Brazil
      • 7.5.2.1.1. Brazil Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.5.2.1.2. Brazil Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.5.2.1.3. Brazil Pharmaceutical Continuous Manufacturing Market, By End User
      • 7.5.2.2. South Africa
      • 7.5.2.2.1. South Africa Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.5.2.2.2. South Africa Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.5.2.2.3. South Africa Pharmaceutical Continuous Manufacturing Market, By End User
      • 7.5.2.3. Saudi Arabia
      • 7.5.2.3.1. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.5.2.3.2. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.5.2.3.3. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By End User
      • 7.5.2.4. Rest of Lamea
      • 7.5.2.4.1. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.5.2.4.2. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.5.2.4.3. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By End User
    • 7.5.3. Lamea Market Size And Forecast, By Product
    • 7.5.4. Lamea Market Size And Forecast, By Application
    • 7.5.5. Lamea Market Size And Forecast, By End User

Chapter 8: Company Profiles

  • 8.1. Coperion Gmbh
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Operating Business Segments
    • 8.1.4. Product Portfolio
    • 8.1.5. Key Strategic Moves And Developments
  • 8.2. Gea Group Ag
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Operating Business Segments
    • 8.2.4. Product Portfolio
    • 8.2.5. Business Performance
  • 8.3. Gebruder Lodige Maschinenbau Gmbh
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Operating Business Segments
    • 8.3.4. Product Portfolio
  • 8.4. Glatt Gmbh
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Operating Business Segments
    • 8.4.4. Product Portfolio
  • 8.5. Hosokawa Micron Corporation
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Product Portfolio
    • 8.5.4. Business Performance
  • 8.6. Korsch Ag
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Operating Business Segments
    • 8.6.4. Product Portfolio
  • 8.7. L.B. Bohle Maschinen + Verfahren Gmbh
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Operating Business Segments
    • 8.7.4. Product Portfolio
  • 8.8. Munson Machinery Company, Inc.
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Operating Business Segments
    • 8.8.4. Product Portfolio
  • 8.9. Robert Bosch Packaging Technology Gmbh
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Operating Business Segments
    • 8.9.4. Product Portfolio
    • 8.9.5. Business Performance
  • 8.10. Thermo Fisher Scientific, Inc.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Operating Business Segments
    • 8.10.4. Product Portfolio
    • 8.10.5. Business Performance

List of Tables

Table 01. Global Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026 ($Million)

Table 02. Integrated Continuous Systems Market, By Region, 2018-2026 ($Million)

Table 03. Semi-Continuous Systems Market, By Region, 2018-2026 ($Million)

Table 04. Others Market, By Region, 2018-2026 ($Million)

Table 05. Global Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026 ($Million)

Table 06. Final Drug Product Manufacturing Market, By Region, 2018-2026 ($Million)

Table 07. Api Manufacturing Market, By Region, 2018-2026 ($Million)

Table 08. Global Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026 ($Million)

Table 09. Pharmaceutical Continuous Manufacturing For Pharmaceutical Companies Market, By Region, 2018-2026 ($Million)

Table 10. Pharmaceutical Continuous Manufacturing For Contract Manufacturing Organizations, By Region, 2018-2026 ($Million)

Table 11. Pharmaceutical Continuous Manufacturing For Others, By Region, 2018-2026 ($Million)

Table 12. Pharmaceutical Continuous Manufacturing Market Revenue, By Region, 2018-2026 ($Million)

Table 13. North America Pharmaceutical Continuous Manufacturing Market, By Country, 2018-2026 ($Million)

Table 14. U.S. Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 15. U.S. Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 16. U.S. Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 17. Canada Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 18. Canada Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 19. Canada Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 20. Mexico Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 21. Mexico Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 22. Mexico Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 23. North America Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 24. North America Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 25. North America Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 26. Europe Pharmaceutical Continuous Manufacturing Market, By Country, 2018-2026 ($Million)

Table 27. Germany Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 28. Germany Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 29. Germany Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 30. France Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 31. France Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 32. France Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 33. Uk Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 34. Uk Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 35. Uk Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 36. Italy Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 37. Italy Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 38. Italy Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 39. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 40. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 41. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 42. Europe Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 43. Europe Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 44. Europe Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 45. Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Country, 2018-2026 ($Million)

Table 46. Japan Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 47. Japan Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 48. Japan Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 49. China Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 50. China Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 51. China Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 52. India Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 53. India Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 54. India Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 55. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 56. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 57. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 58. Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 59. Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 60. Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 61. Lamea Pharmaceutical Continuous Manufacturing Market, By Country, 2018-2026 ($Million)

Table 62. Brazil Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 63. Brazil Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 64. Brazil Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 65. South Africa Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 66. South Africa Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 67. South Africa Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 68. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 69. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 70. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 71. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 72. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 73. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 74. Lamea Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 75. Lamea Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 76. Lamea Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 77. Coperion: Company Snapshot

Table 78. Coperion: Business Segment

Table 79. Gea Group: Company Snapshot

Table 80. Gea Group: Operating Segments

Table 81. Gea Group: Product Portfolio

Table 82. Lodige: Company Snapshot

Table 83. Lodige: Operating Segments

Table 84. Lodige: Product Portfolio

Table 85. Glatt: Company Snapshot

Table 86. Glatt: Operating Segments

Table 87. Glatt: Product Portfolio

Table 88. Hosokawa: Company Snapshot

Table 89. Hosokawa: Product Portfolio

Table 90. Korsch: Company Snapshot

Table 91. Korsch: Operating Segments

Table 92. Korsch: Product Portfolio

Table 93. L.B. Bohle: Company Snapshot

Table 94. L.B. Bohle: Operating Segments

Table 95. Munson: Company Snapshot

Table 96. L.B. Bohle: Operating Product Segments

Table 97. Munson: Product Portfolio

Table 98. Bosch Group: Company Snapshot

Table 99. Bosch Group: Operating Segments

Table 100. Bosch Group: Product Portfolio

Table 101. Thermo Fisher Scientific: Company Snapshot

Table 102. Thermo Fisher Scientific: Operating Segments

Table 103. Thermo Fisher Scientific: Product Portfolio

List of Figures

Figure 01. Global Pharmaceutical Continuous Manufacturing Market Segmentation

Figure 02. Top Investment Pockets, 2018

Figure 03. Market Player Positioning, 2018

Figure 04. Impact Analysis

Figure 05. Comparative Analysis of Integrated Continuous Systems Market, By Country, 2018 & 2026 ($Million)

Figure 06. Comparative Analysis of Semi-Continuous Systems Market, By Country, 2018 & 2026 ($Million)

Figure 07. Comparative Analysis of Control & Software Market, By Country, 2018 & 2026 ($Million)

Figure 08. Comparative Analysis of Final Drug Product Manufacturing Market, By Country, 2018 & 2026 ($Million)

Figure 09. Comparative Analysis of Api Manufacturing Market, By Country, 2018 & 2026 ($Million)

Figure 10. Comparative Analysis of Pharmaceutical Continuous Manufacturing For Pharmaceutical Companies Market, By Country, 2018 & 2026 ($Million)

Figure 11. Comparative Analysis Pharmaceutical Continuous Manufacturing Market For Contract Manufacturing Organizations, By Country, 2018 & 2026 (%)

Figure 12. Comparative Analysis of Pharmaceutical Continuous Manufacturing Market For Others, By Country, 2018 & 2026 (%)

Figure 13. Net Sales, 2016-2018 ($Million)

Figure 14. Gea Group: Net Sales By Segment, 2018 (%)

Figure 15. Gea Group: Net Sales By Region, 2018 (%)

Figure 16. Net Sales, 2016-2018 ($Million)

Figure 17. Hosokawa: Net Sales By Segment, 2018 (%)

Figure 18. Hosokawa: Net Sales By Geography, 2018 (%)

Figure 19. Net Sales, 2016-2018 ($Million)

Figure 20. Bosch Group: Net Sales By Segment, 2018 (%)

Figure 21. Bosch Group: Net Sales By Revenue, 2018 (%)

Figure 22. Thermo Fisher Scientific: Revenue, 2016-2018 ($Million)

Figure 23. Thermo Fisher Scientific: Revenue Share, By Segment, 2018 (%)

Figure 24. Thermo Fisher Scientific: Revenue Share, By Region, 2018 (%)